Figure 1.
Pmel-1 CTLA-4–/– mice develop autoimmune vitiligo at an accelerated rate compared with pmel-1 CTLA-4+/+ mice. Development of autoimmune vitiligo in a pmel-1 CTLA-4–/– mouse. Pictured are pmel-1 CTLA+/+ (right) and pmel-1 CTLA-4–/– (left) littermates at 6 weeks of age. Autoimmune vitiligo is present over more than 75% of the body surface of the pmel-1 CTLA-4–/– mouse.